YKL-40 in asthmatic patients, and its correlations with exacerbation, eosinophils and immunoglobulin E

Tang H., Fang Z., Sun Y., Li B., Shi Z., Chen J., Zhang T., Xiu Q.

Source: Eur Respir J 2010; 35: 757-760
Journal Issue: April
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Tang H., Fang Z., Sun Y., Li B., Shi Z., Chen J., Zhang T., Xiu Q.. YKL-40 in asthmatic patients, and its correlations with exacerbation, eosinophils and immunoglobulin E. Eur Respir J 2010; 35: 757-760

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Study on levels of high sensitivity C reactive protein in asthmatic patients during exacerbation and remission and its correlation with pulmonary function
Source: Annual Congress 2007 - Mechanisms of airway inflammation
Year: 2007



Ciclesonide 80 μg once daily reduces early and late asthmatic reaction, sputum eosinophils and serum ECP in asthma patients challenged with allergens
Source: Eur Respir J 2005; 26: Suppl. 49, 254s
Year: 2005

Correlation between sputum and blood eosinophils in asthmatic and COPD patients with comorbidities.
Source: International Congress 2018 – Airway disease: recent discoveries
Year: 2018

Pathogenesis of occupational asthma
Source: Eur Respir J 2003; 22: 364-373
Year: 2003



One year monitoring of children with bronchial asthma and other allergic diseases treated with inhaled corticosteroids vs cromoglycates with serum ECP (S-ECP), FEV1, total IgE and blood eosinophil count - the influence of different therapy
Source: Eur Respir J 2002; 20: Suppl. 38, 432s
Year: 2002

Eotaxin in serum and sputum: comparison between normal and allergic asthmatic children
Source: Eur Respir J 2004; 24: Suppl. 48, 163s
Year: 2004

Pharmacodynamic effect of benralizumab on blood basophils and serum biomarkers in adults with COPD with sputum eosinophilia
Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD
Year: 2015

The effects of IL12B promoter polymorphism on co-existence of allergic rhinitis or familial asthma history, serum total IgE and eosinophil level in asthma patients
Source: Annual Congress 2008 - Advances in functional genomics of neoplastic and non-neoplastic lung diseases
Year: 2008


Correlation between plasma levels of IL-33 and Vitamin D in patients with severe uncontrolled allergic asthma
Source: International Congress 2017 – Novel mechanisms in asthma
Year: 2017


Airway eosinophilia is not related to clinical and functional findings in a large group of severe refractory asthmatics
Source: Annual Congress 2006 - Monitoring airway inflammation – exhaled markers vs induced sputum
Year: 2006


Interaction between eotaxin and IL-13 in serum and sputum: comparison between normal and allergic asthmatic children
Source: Eur Respir J 2004; 24: Suppl. 48, 396s
Year: 2004

Elevated serum IgE, oral corticosteroid dependence and IL-17/22 expression in highly neutrophilic asthma
Source: Eur Respir J, 54 (5) 1900068; 10.1183/13993003.00068-2019
Year: 2019



Correlations between exacerbation rate and blood eosinophil levels in COPD patients
Source: International Congress 2017 – Infection and exacerbation science
Year: 2017

Correlation between total serum immunoglobulin E and allergen specific immunoglobulin E in children with allergic disease
Source: Annual Congress 2009 - New developments in preschool wheezing disorders and its genetic basis
Year: 2009

Serum levels of interleukin-18 in patients affected by allergic bronchial asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 30s
Year: 2002

Regular salbutamol use increases CXCL8 responses in asthma: relationship to the eosinophil response
Source: Eur Respir J 2003; 22: 118-126
Year: 2003



IL-4, IFN-gamma and TNF-alpha levels in serum of patients with COPD, bronchial asthma and GERD
Source: Annual Congress 2012 - Inflammatory mechanisms in COPD
Year: 2012

The interaction between leptin and inflammatory markers in induced sputum in patients with moderate COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 404s
Year: 2002

Activin-A levels in sputum and serum of COPD, asthma and ACOS patients during acute exacerbation and at baseline
Source: International Congress 2017 – Infection and exacerbation science
Year: 2017

Analysis of IgE and C-reactive protein as possible predictors of exacerbation patients with asthma
Source: Annual Congress 2011 - Biomarkers of allergic inflammation
Year: 2011